{"entity":{"type":"insider","cik":"0001640322","url":"/insider/0001640322","json_url":"/insider/0001640322.json","name":"Nussbaum Robert L","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":32,"n_filings":22,"first":"2017-02-15","last":"2023-06-15","span_basis":"filed_date"},"name_variants":[{"name":"Nussbaum Robert L","source":"filing","n_filings":22,"first_seen":"2017-02-15","last_seen":"2023-06-15"}],"transactions":[{"id":8064648,"accession":"0000950170-23-028349","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-028349","line_url":"/filing/0000950170-23-028349#line-1","is_derivative":false,"issuer_cik":"0001501134","issuer_name":"Invitae Corp","issuer_ticker":"NVTA","issuer_name_source":null,"issuer_url":"/issuer/0001501134","owner_cik":"0001640322","owner_name":"Nussbaum Robert L","owner_display_name":"Nussbaum Robert L","owner_url":"/insider/0001640322","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7086.0,"shares_display":"7,086","price_per_share":1.377,"price_display":"1.38","price_state":"stated","total_value":9757.422,"total_display":"9,757.42","total_whole":"9,757","shares_owned_after":569345.0,"shares_owned_after_display":"569,345","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-13","filed_date":"2023-06-15","scope":"insider"},{"id":8244597,"accession":"0000899243-23-013235","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-013235","line_url":"/filing/0000899243-23-013235#line-1","is_derivative":false,"issuer_cik":"0001501134","issuer_name":"Invitae Corp","issuer_ticker":"NVTA","issuer_name_source":null,"issuer_url":"/issuer/0001501134","owner_cik":"0001640322","owner_name":"Nussbaum Robert L","owner_display_name":"Nussbaum Robert L","owner_url":"/insider/0001640322","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26476.0,"shares_display":"26,476","price_per_share":1.1993,"price_display":"1.20","price_state":"stated","total_value":31752.6668,"total_display":"31,752.67","total_whole":"31,753","shares_owned_after":576431.0,"shares_owned_after_display":"576,431","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-16","filed_date":"2023-05-18","scope":"insider"},{"id":7801033,"accession":"0000950170-23-008158","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-008158","line_url":"/filing/0000950170-23-008158#line-1","is_derivative":false,"issuer_cik":"0001501134","issuer_name":"Invitae Corp","issuer_ticker":"NVTA","issuer_name_source":null,"issuer_url":"/issuer/0001501134","owner_cik":"0001640322","owner_name":"Nussbaum Robert L","owner_display_name":"Nussbaum Robert L","owner_url":"/insider/0001640322","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2625.0,"shares_display":"2,625","price_per_share":1.41,"price_display":"1.41","price_state":"stated","total_value":3701.25,"total_display":"3,701.25","total_whole":"3,701","shares_owned_after":447907.0,"shares_owned_after_display":"447,907","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-13","filed_date":"2023-03-15","scope":"insider"},{"id":6670438,"accession":"0000899243-22-029156","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-029156","line_url":"/filing/0000899243-22-029156#line-1","is_derivative":false,"issuer_cik":"0001501134","issuer_name":"Invitae Corp","issuer_ticker":"NVTA","issuer_name_source":null,"issuer_url":"/issuer/0001501134","owner_cik":"0001640322","owner_name":"Nussbaum Robert L","owner_display_name":"Nussbaum Robert L","owner_url":"/insider/0001640322","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7048.0,"shares_display":"7,048","price_per_share":4.5503,"price_display":"4.55","price_state":"stated","total_value":32070.5144,"total_display":"32,070.51","total_whole":"32,071","shares_owned_after":396532.0,"shares_owned_after_display":"396,532","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-16","filed_date":"2022-08-18","scope":"insider"},{"id":6341704,"accession":"0000899243-22-018871","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-018871","line_url":"/filing/0000899243-22-018871#line-1","is_derivative":false,"issuer_cik":"0001501134","issuer_name":"Invitae Corp","issuer_ticker":"NVTA","issuer_name_source":null,"issuer_url":"/issuer/0001501134","owner_cik":"0001640322","owner_name":"Nussbaum Robert L","owner_display_name":"Nussbaum Robert L","owner_url":"/insider/0001640322","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6098.0,"shares_display":"6,098","price_per_share":3.8101,"price_display":"3.81","price_state":"stated","total_value":23233.9898,"total_display":"23,233.99","total_whole":"23,234","shares_owned_after":403580.0,"shares_owned_after_display":"403,580","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-17","filed_date":"2022-05-19","scope":"insider"},{"id":6645073,"accession":"0000899243-22-011321","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-011321","line_url":"/filing/0000899243-22-011321#line-2","is_derivative":false,"issuer_cik":"0001501134","issuer_name":"Invitae Corp","issuer_ticker":"NVTA","issuer_name_source":null,"issuer_url":"/issuer/0001501134","owner_cik":"0001640322","owner_name":"Nussbaum Robert L","owner_display_name":"Nussbaum Robert L","owner_url":"/insider/0001640322","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19588.0,"shares_display":"19,588","price_per_share":6.6874,"price_display":"6.69","price_state":"stated","total_value":130992.7912,"total_display":"130,992.79","total_whole":"130,993","shares_owned_after":241167.0,"shares_owned_after_display":"241,167","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-14","filed_date":"2022-03-16","scope":"insider"},{"id":4357512,"accession":"0000899243-21-044611","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-21-044611","line_url":"/filing/0000899243-21-044611#line-3","is_derivative":false,"issuer_cik":"0001501134","issuer_name":"Invitae Corp","issuer_ticker":"NVTA","issuer_name_source":null,"issuer_url":"/issuer/0001501134","owner_cik":"0001640322","owner_name":"Nussbaum Robert L","owner_display_name":"Nussbaum Robert L","owner_url":"/insider/0001640322","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29675.0,"shares_display":"29,675","price_per_share":21.8894,"price_display":"21.89","price_state":"stated","total_value":649567.945,"total_display":"649,567.94","total_whole":"649,568","shares_owned_after":246050.0,"shares_owned_after_display":"246,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-11","filed_date":"2021-11-15","scope":"insider"},{"id":5132794,"accession":"0000899243-21-033561","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-033561","line_url":"/filing/0000899243-21-033561#line-1","is_derivative":false,"issuer_cik":"0001501134","issuer_name":"Invitae Corp","issuer_ticker":"NVTA","issuer_name_source":null,"issuer_url":"/issuer/0001501134","owner_cik":"0001640322","owner_name":"Nussbaum Robert L","owner_display_name":"Nussbaum Robert L","owner_url":"/insider/0001640322","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21231.0,"shares_display":"21,231","price_per_share":25.4172,"price_display":"25.42","price_state":"stated","total_value":539632.5732,"total_display":"539,632.57","total_whole":"539,633","shares_owned_after":246050.0,"shares_owned_after_display":"246,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-16","filed_date":"2021-08-18","scope":"insider"},{"id":4356661,"accession":"0000899243-21-024194","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-024194","line_url":"/filing/0000899243-21-024194#line-1","is_derivative":false,"issuer_cik":"0001501134","issuer_name":"Invitae Corp","issuer_ticker":"NVTA","issuer_name_source":null,"issuer_url":"/issuer/0001501134","owner_cik":"0001640322","owner_name":"Nussbaum Robert L","owner_display_name":"Nussbaum Robert L","owner_url":"/insider/0001640322","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9910.0,"shares_display":"9,910","price_per_share":31.6251,"price_display":"31.63","price_state":"stated","total_value":313404.741,"total_display":"313,404.74","total_whole":"313,405","shares_owned_after":266879.0,"shares_owned_after_display":"266,879","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-14","filed_date":"2021-06-16","scope":"insider"},{"id":9204857,"accession":"0000899243-21-012769","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-012769","line_url":"/filing/0000899243-21-012769","is_derivative":false,"issuer_cik":"0001501134","issuer_name":"Invitae Corp","issuer_ticker":"NVTA","issuer_name_source":null,"issuer_url":"/issuer/0001501134","owner_cik":"0001640322","owner_name":"Nussbaum Robert L","owner_display_name":"Nussbaum Robert L","owner_url":"/insider/0001640322","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18159.0,"shares_display":"18,159","price_per_share":42.9006,"price_display":"42.90","price_state":"stated","total_value":779031.9954,"total_display":"779,032.00","total_whole":"779,032","shares_owned_after":232089.0,"shares_owned_after_display":"232,089","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-15","filed_date":"2021-03-19","scope":"insider","n_lines":2},{"id":5363593,"accession":"0000899243-21-012381","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-21-012381","line_url":"/filing/0000899243-21-012381","is_derivative":false,"issuer_cik":"0001501134","issuer_name":"Invitae Corp","issuer_ticker":"NVTA","issuer_name_source":null,"issuer_url":"/issuer/0001501134","owner_cik":"0001640322","owner_name":"Nussbaum Robert L","owner_display_name":"Nussbaum Robert L","owner_url":"/insider/0001640322","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18159.0,"shares_display":"18,159","price_per_share":42.9006,"price_display":"42.90","price_state":"stated","total_value":779031.9954,"total_display":"779,032.00","total_whole":"779,032","shares_owned_after":238354.0,"shares_owned_after_display":"238,354","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-12","filed_date":"2021-03-17","scope":"insider","n_lines":2},{"id":2314877,"accession":"0001501134-20-000059","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001501134-20-000059","line_url":"/filing/0001501134-20-000059","is_derivative":false,"issuer_cik":"0001501134","issuer_name":"Invitae Corp","issuer_ticker":"NVTA","issuer_name_source":null,"issuer_url":"/issuer/0001501134","owner_cik":"0001640322","owner_name":"Nussbaum Robert L","owner_display_name":"Nussbaum Robert L","owner_url":"/insider/0001640322","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23175.0,"shares_display":"23,175","price_per_share":33.56253032578209,"price_display":"33.56","price_state":"stated","total_value":777811.6403,"total_display":"777,811.64","total_whole":"777,812","shares_owned_after":210391.0,"shares_owned_after_display":"210,391","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-10","filed_date":"2020-09-14","scope":"insider","n_lines":4},{"id":2459017,"accession":"0001501134-20-000046","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001501134-20-000046","line_url":"/filing/0001501134-20-000046#line-1","is_derivative":false,"issuer_cik":"0001501134","issuer_name":"Invitae Corp","issuer_ticker":"NVTA","issuer_name_source":null,"issuer_url":"/issuer/0001501134","owner_cik":"0001640322","owner_name":"Nussbaum Robert L","owner_display_name":"Nussbaum Robert L","owner_url":"/insider/0001640322","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19049.0,"shares_display":"19,049","price_per_share":32.0961,"price_display":"32.10","price_state":"stated","total_value":611398.6089,"total_display":"611,398.61","total_whole":"611,399","shares_owned_after":230730.0,"shares_owned_after_display":"230,730","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-19","filed_date":"2020-08-20","scope":"insider"},{"id":2632634,"accession":"0000899243-20-019008","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-019008","line_url":"/filing/0000899243-20-019008","is_derivative":false,"issuer_cik":"0001501134","issuer_name":"Invitae Corp","issuer_ticker":"NVTA","issuer_name_source":null,"issuer_url":"/issuer/0001501134","owner_cik":"0001640322","owner_name":"Nussbaum Robert L","owner_display_name":"Nussbaum Robert L","owner_url":"/insider/0001640322","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29783.0,"shares_display":"29,783","price_per_share":34.150747893093374,"price_display":"34.15","price_state":"stated","total_value":1017111.7245,"total_display":"1,017,111.72","total_whole":"1,017,112","shares_owned_after":251229.0,"shares_owned_after_display":"251,229","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-09","filed_date":"2020-07-13","scope":"insider","n_lines":3},{"id":2895033,"accession":"0000899243-20-014080","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-014080","line_url":"/filing/0000899243-20-014080","is_derivative":false,"issuer_cik":"0001501134","issuer_name":"Invitae Corp","issuer_ticker":"NVTA","issuer_name_source":null,"issuer_url":"/issuer/0001501134","owner_cik":"0001640322","owner_name":"Nussbaum Robert L","owner_display_name":"Nussbaum Robert L","owner_url":"/insider/0001640322","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19893.0,"shares_display":"19,893","price_per_share":17.280599467149248,"price_display":"17.28","price_state":"stated","total_value":343762.9652,"total_display":"343,762.97","total_whole":"343,763","shares_owned_after":203446.0,"shares_owned_after_display":"203,446","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-22","filed_date":"2020-05-22","scope":"insider","n_lines":2},{"id":2895021,"accession":"0000899243-20-014080","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-014080","line_url":"/filing/0000899243-20-014080#line-1","is_derivative":false,"issuer_cik":"0001501134","issuer_name":"Invitae Corp","issuer_ticker":"NVTA","issuer_name_source":null,"issuer_url":"/issuer/0001501134","owner_cik":"0001640322","owner_name":"Nussbaum Robert L","owner_display_name":"Nussbaum Robert L","owner_url":"/insider/0001640322","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6864.0,"shares_display":"6,864","price_per_share":16.7008,"price_display":"16.70","price_state":"stated","total_value":114634.2912,"total_display":"114,634.29","total_whole":"114,634","shares_owned_after":220305.0,"shares_owned_after_display":"220,305","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-20","filed_date":"2020-05-22","scope":"insider"},{"id":2328120,"accession":"0000899243-20-008544","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-008544","line_url":"/filing/0000899243-20-008544#line-2","is_derivative":false,"issuer_cik":"0001501134","issuer_name":"Invitae Corp","issuer_ticker":"NVTA","issuer_name_source":null,"issuer_url":"/issuer/0001501134","owner_cik":"0001640322","owner_name":"Nussbaum Robert L","owner_display_name":"Nussbaum Robert L","owner_url":"/insider/0001640322","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10684.0,"shares_display":"10,684","price_per_share":11.79,"price_display":"11.79","price_state":"stated","total_value":125964.36,"total_display":"125,964.36","total_whole":"125,964","shares_owned_after":227169.0,"shares_owned_after_display":"227,169","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-16","filed_date":"2020-03-16","scope":"insider"},{"id":7992095,"accession":"0000899243-19-022245","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-022245","line_url":"/filing/0000899243-19-022245#line-1","is_derivative":false,"issuer_cik":"0001501134","issuer_name":"Invitae Corp","issuer_ticker":"NVTA","issuer_name_source":null,"issuer_url":"/issuer/0001501134","owner_cik":"0001640322","owner_name":"Nussbaum Robert L","owner_display_name":"Nussbaum Robert L","owner_url":"/insider/0001640322","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20447.0,"shares_display":"20,447","price_per_share":25.2943,"price_display":"25.29","price_state":"stated","total_value":517192.5521,"total_display":"517,192.55","total_whole":"517,193","shares_owned_after":146120.0,"shares_owned_after_display":"146,120","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-19","filed_date":"2019-08-21","scope":"insider"},{"id":8471632,"accession":"0000899243-19-014387","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-014387","line_url":"/filing/0000899243-19-014387#line-1","is_derivative":false,"issuer_cik":"0001501134","issuer_name":"Invitae Corp","issuer_ticker":"NVTA","issuer_name_source":null,"issuer_url":"/issuer/0001501134","owner_cik":"0001640322","owner_name":"Nussbaum Robert L","owner_display_name":"Nussbaum Robert L","owner_url":"/insider/0001640322","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7202.0,"shares_display":"7,202","price_per_share":18.21,"price_display":"18.21","price_state":"stated","total_value":131148.42,"total_display":"131,148.42","total_whole":"131,148","shares_owned_after":166567.0,"shares_owned_after_display":"166,567","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-20","filed_date":"2019-05-22","scope":"insider"},{"id":7991556,"accession":"0000899243-19-001159","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-001159","line_url":"/filing/0000899243-19-001159#line-1","is_derivative":false,"issuer_cik":"0001501134","issuer_name":"Invitae Corp","issuer_ticker":"NVTA","issuer_name_source":null,"issuer_url":"/issuer/0001501134","owner_cik":"0001640322","owner_name":"Nussbaum Robert L","owner_display_name":"Nussbaum Robert L","owner_url":"/insider/0001640322","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5222.0,"shares_display":"5,222","price_per_share":14.0087,"price_display":"14.01","price_state":"stated","total_value":73153.4314,"total_display":"73,153.43","total_whole":"73,153","shares_owned_after":163769.0,"shares_owned_after_display":"163,769","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-10","filed_date":"2019-01-14","scope":"insider"},{"id":9204626,"accession":"0000899243-19-001157","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-001157","line_url":"/filing/0000899243-19-001157","is_derivative":false,"issuer_cik":"0001640322","issuer_name":"Invitae Corp","issuer_ticker":"NVTA","issuer_name_source":null,"issuer_url":"/issuer/0001640322","owner_cik":"0001640322","owner_name":"Nussbaum Robert L","owner_display_name":"Nussbaum Robert L","owner_url":"/insider/0001640322","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10444.0,"shares_display":"10,444","price_per_share":13.114105553427805,"price_display":"13.11","price_state":"stated","total_value":136963.7184,"total_display":"136,963.72","total_whole":"136,964","shares_owned_after":168991.0,"shares_owned_after_display":"168,991","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-12","filed_date":"2019-01-14","scope":"insider","n_lines":2},{"id":6677983,"accession":"0000899243-18-013132","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-18-013132","line_url":"/filing/0000899243-18-013132#line-1","is_derivative":false,"issuer_cik":"0001501134","issuer_name":"Invitae Corp","issuer_ticker":"NVTA","issuer_name_source":null,"issuer_url":"/issuer/0001501134","owner_cik":"0001640322","owner_name":"Nussbaum Robert L","owner_display_name":"Nussbaum Robert L","owner_url":"/insider/0001640322","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6702.0,"shares_display":"6,702","price_per_share":6.96,"price_display":"6.96","price_state":"stated","total_value":46645.92,"total_display":"46,645.92","total_whole":"46,646","shares_owned_after":54435.0,"shares_owned_after_display":"54,435","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-15","filed_date":"2018-05-16","scope":"insider"},{"id":4728491,"accession":"0000899243-17-004278","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-17-004278","line_url":"/filing/0000899243-17-004278#line-2","is_derivative":false,"issuer_cik":"0001501134","issuer_name":"Invitae Corp","issuer_ticker":"NVTA","issuer_name_source":null,"issuer_url":"/issuer/0001501134","owner_cik":"0001640322","owner_name":"Nussbaum Robert L","owner_display_name":"Nussbaum Robert L","owner_url":"/insider/0001640322","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1686.0,"shares_display":"1,686","price_per_share":9.53,"price_display":"9.53","price_state":"stated","total_value":16067.58,"total_display":"16,067.58","total_whole":"16,068","shares_owned_after":61137.0,"shares_owned_after_display":"61,137","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-15","filed_date":"2017-02-15","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":32,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":32,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":32},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001501134","name":"Invitae Corp","url":"/issuer/0001501134","role":"Officer (Chief Medical Officer)","n_filings":22,"first_seen":"2017-02-15","last_seen":"2023-06-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001640322","retrieved_at":"2026-08-22T12:11:06+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}